Cargando…
Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer
INTRODUCTION: Fusobacterium nucleatum (F. nucleatum) infection has been confirmed to be associated with the development, chemoresistance, and immune evasion of colorectal cancer (CRC). The complex relationship between the microorganism, host cells, and the immune system throughout all stages of CRC...
Autores principales: | Tong, Yanan, Lu, Guoxiu, Wang, Zhiguo, Hao, Shanhu, Zhang, Guoxu, Sun, Hongwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189021/ https://www.ncbi.nlm.nih.gov/pubmed/37207216 http://dx.doi.org/10.3389/fimmu.2023.1154818 |
Ejemplares similares
-
Fusobacterium nucleatum and Colorectal Cancer
por: Li, Rongrong, et al.
Publicado: (2022) -
Involvement of Fusobacterium nucleatum in malignancies except for colorectal cancer: A literature review
por: He, Zhixing, et al.
Publicado: (2022) -
Fusobacterium nucleatum-positive colorectal cancer
por: Yang, Zhenhua, et al.
Publicado: (2019) -
Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis
por: Lamprinaki, Dimitra, et al.
Publicado: (2021) -
Fusobacterium nucleatum and colorectal cancer: A review
por: Shang, Fu-Mei, et al.
Publicado: (2018)